Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01072461 · ClinicalTrials.gov registry record · Phase 1
Optimizing Hand Rehabilitation Post-Stroke Using Interactive Virtual Environments
A Phase 1 study, sponsored by New Jersey Institute of Technology.
- Completed
- Registry status
- Phase 1
- Development phase
- 55
- Enrollment target
NCT01072461: Completed Phase 1 study, sponsored by New Jersey Institute of Technology.
NCT01072461 is a Phase 1 study that has completed, run by New Jersey Institute of Technology. The registered enrollment target is 55 participants, roughly in line with the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01072461, a Phase 1 study, has completed, sponsored by New Jersey Institute of Technology.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 55 participants
- Enrollment target
Study Summary
The complexity of sensorimotor control required for hand function as well as the wide range of recovery of manipulative abilities makes rehabilitation of the hand most challenging. The investigators past work has shown that training in a virtual environment (VE) using repetitive, adaptive algorithms has the potential to be an effective rehabilitation medium to facilitate motor recovery of hand function. These findings are in accordance with current neuroscience literature in animals and motor control literature in humans. The investigators are now in a position to refine and optimize elements of the training paradigms to enhance neuroplasticity. The investigators first aim tests if and how competition among body parts for neural representations stifles functional gains from different types of training regimens. The second aim tests the functional benefits of unilateral versus bilateral training regimens.The third aim tests whether functional improvements gained from training in a virtual environment transfer to other (untrained) skills in the real world.
Interventions
- BEHAVIORAL HAS Training
- BEHAVIORAL HAT training
- BEHAVIORAL Bimanual Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2009-03 |
| Est. Completion | 2015-03 |
| Phase | Phase 1 |
What the finished NCT01072461 record still lists
NCT01072461 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 55 participants, a relatively small participant target, roughly in line with the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target.
The record links to 0 conditions, and to 3 interventions - of which HAS Training is the first listed.
NCT01072461 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01072461 about?
NCT01072461 is a clinical study titled "Optimizing Hand Rehabilitation Post-Stroke Using Interactive Virtual Environments". The complexity of sensorimotor control required for hand function as well as the wide range of recovery of manipulative abilities makes rehabilitation of the hand most challenging. The investigators past work has shown that training in a virtual environment (VE) using repetitive, adaptive algorithms...
What is the current status of trial NCT01072461?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 55 participants. The study started on 2009-03. Estimated completion is 2015-03.
What interventions are being tested in trial NCT01072461?
The interventions under investigation include: HAS Training (BEHAVIORAL), HAT training (BEHAVIORAL), Bimanual Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT01072461?
This trial is sponsored by New Jersey Institute of Technology, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01072461's enrollment target sits among peer trials
55 918th of 2000 higher than 1,070 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01638676 · 55 participants · Phase 1
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
- NCT01906385 · 55 participants · Phase 1
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- NCT03007030 · 55 participants · Phase 2
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
- NCT03152058 · 55 participants · Phase 2
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia